This makes xnpt less encumbered (for a buy out) and allows xnpt to market two drugs and all profits
as DEPO has done with gralise Over all Great news for xnpts future
GSK has invested $20million and perhaps $20million more at a 12% premium over the stock price this indicates they believe in the value of xnpts drugs coming to market
GSK has now bought another$ 20million of xnpt for a total of $40million---They may just buy the company as AP and 829 get nearer to market
Hey , wmjack50 , I see you are sharp - what other stocks do you like ?
I , got some in XNPT and want to stay disversified - I just took a loss on another
so I do not want everything on one stock. Small investor Thanks , John
They are offering stock options at $8plus level to the marketing team --expect higher prices for xnpt as the marketing team works to make these options pay